Palo Alto California based Pheast Therapeutics is raising $76,000,000.00 in New Equity Investment.
Palo Alto, CA – According to filings with the U.S. Securities and Exchange Commission, Pheast Therapeutics is raising $76,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Amira Barkal played…